Biosyntia Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $17.4M

  • Investors
  • 10

Biosyntia General Information

Description

Developer and manufacturer of bio-catalysts designed to provide complex chemical compounds by fermentation. The company's bio-catalysts are chemical compounds that include flavors, fragrances, APIs, pigments, additives, intermediates, and vitamins by applying synthetic biology and metabolic engineering, enabling clients to establish greener and more sustainable manufacturing processes for their production purposes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Multi-line Chemicals
Corporate Office
  • Fruebjergvej 3, boks 54
  • 2100 Copenhagen
  • Denmark

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosyntia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 30-Sep-2022 $17.4M 0000 Completed Generating Revenue
6. Later Stage VC (Series A) 23-May-2018 00.000 00.000 00.00 Completed Generating Revenue
5. Seed Round 21-May-2015 00.000 00.000 00.000 Completed Generating Revenue
4. Grant 01-Dec-2013 Completed Startup
3. Grant 01-Jun-2013 0000 Completed Startup
2. Grant 01-Nov-2012 $145K Completed Startup
1. Spin-Off 01-Jan-2012 Completed Startup
To view Biosyntia’s complete valuation and funding history, request access »

Biosyntia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 000,000 000.00 000.00 00 000.00 00.000
Series B 00,000 000.00 000.00 00 000.00 00.000
Series B 29,333 $30.04 $30.04 1x $30.04 10.22%
To view Biosyntia’s complete cap table history, request access »

Biosyntia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and manufacturer of bio-catalysts designed to provide complex chemical compounds by fermentation. The company'
Biotechnology
Copenhagen, Denmark
26 As of 2023
0000
00000000000 0000

0000

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor i
00000 00000000
San Diego, CA
000 As of 0000
00000
00000000000 00000

00000

lla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
0000000000000
Cambridge, MA
000 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biosyntia Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Geno Venture Capital-Backed San Diego, CA 000 00000 00000000000 00000
Manus Bio Venture Capital-Backed Cambridge, MA 000 00000 0000000000 0 00000
Lygos Venture Capital-Backed Berkeley, CA 00 00000 0000000000 0 00000
Viridos Venture Capital-Backed La Jolla, CA 00 00000 00000000000 00000
To view Biosyntia’s complete competitors history, request access »

Biosyntia Patents

Biosyntia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4168566-A1 Methods for producing biotin in genetically modified microorganisms Pending 18-Jun-2020 0000000000
EP-3911666-A1 Cell factories for improved production of compounds and proteins dependent on iron sulfur clusters Pending 16-Jan-2019 0000000000
US-20220127311-A1 Cell factories for improved production of compounds and proteins dependent on iron sulfur clusters Pending 16-Jan-2019 0000000000
EP-3683227-A1 Cell factories for improved production of compounds and proteins dependent on iron sulfur clusters Inactive 16-Jan-2019 0000000000 0
CA-3069650-A1 Cell factory having improved iron-sulfur cluster delivery Pending 14-Jul-2017 C07K14/245
To view Biosyntia’s complete patent history, request access »

Biosyntia Executive Team (5)

Name Title Board Seat Contact Info
Martin Plambech Chief Executive Officer
Hans Genee Ph.D Co-Founder & Chief Science Officer
Andreas Laustsen Ph.D Co-Founder & Business Developer
Morten Sommer Ph.D Co-Founder & Board Member
You’re viewing 4 of 5 executive team members. Get the full list »

Biosyntia Board Members (11)

Name Representing Role Since
Anouck Champsaur Ph.D Sofinnova Partners Board Observer 000 0000
Graham Ellis Praesidium (Luxembourg) Board Observer 000 0000
Henrik Dalbøge Ph.D Self Chairman 000 0000
Joško Bobanović Ph.D Sofinnova Partners Board Member 000 0000
Jowita Sewerska ECBF Management Board Observer 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Biosyntia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosyntia Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Denmark's Export and Investment Fund Venture Capital Minority 000 0000 000000 0
ECBF Management Venture Capital Minority 000 0000 000000 0
Praesidium (Luxembourg) Asset Manager Minority 000 0000 000000 0
Sofinnova Partners Venture Capital Minority 000 0000 000000 0
European Union Seventh Framework Programme Government 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »